Canada Markets closed

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6674+0.0124 (+1.89%)
At close: 04:00PM EDT
0.6657 -0.00 (-0.25%)
After hours: 05:48PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.27
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.6200
52 Week Low 30.5000
50-Day Moving Average 30.7596
200-Day Moving Average 30.8598

Share Statistics

Avg Vol (3 month) 3515.64k
Avg Vol (10 day) 3317.62k
Shares Outstanding 5126.62M
Implied Shares Outstanding 6N/A
Float 8118.83M
% Held by Insiders 10.04%
% Held by Institutions 121.74%
Shares Short (Jan 30, 2023) 48.79M
Short Ratio (Jan 30, 2023) 412.22
Short % of Float (Jan 30, 2023) 46.95%
Short % of Shares Outstanding (Jan 30, 2023) 46.94%
Shares Short (prior month Dec 29, 2022) 49.24M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 19, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Apr 19, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-11.30%
Return on Equity (ttm)-18.33%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -24.37M
Net Income Avi to Common (ttm)-24.3M
Diluted EPS (ttm)-1.9750
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)117.37M
Total Cash Per Share (mrq)0.93
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)43.03
Book Value Per Share (mrq)0.56

Cash Flow Statement

Operating Cash Flow (ttm)-19.9M
Levered Free Cash Flow (ttm)-10.28M